Alcohol use disorder (AUD) is a brain disorder affecting more than 28 million adults in the United States, according to the AUD is characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences
Get a second opinion from trusted experts and makeconfident, informed decisions
GLP-1 receptor agonists and related incretin-based peptides reduce HbA1c, body weight and certain cardiovascular risk markers in appropriate patients, especially when combined with nutrition and activity interventions
By examining current evidence from cellular, animal, and clinical studies, this review aims to provide a detailed evaluation of sulforaphanes potential as a neuroprotective agent in neurological disease treatment and prevention
The combined effect is greater than either lever alone, which is why 15 mg of tirzepatide produces weight loss that 2.4 mg of semaglutide cannot match